GANX
Gain Therapeutics, Inc.
$1.91
-0.08 (-4.02%)
At close · Jul 2
Market Cap
$81.47M
Shares
42,654,038
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.